Prymula R, Motlova J, Kriz P
Purkyne Military Medical Academy, Hradec Kralove, Prague, Czech Republic.
Indian J Med Res. 2004 May;119 Suppl:168-70.
BACKGROUND & OBJECTIVES: The availability of a type-specific pneumococcal vaccine for children is a worldwide problem. It is necessary to study the serotypes prevalent in a country before introducing a type-specific vaccine. The objective of the present study was to analyse the prevalence of Streptococcus pneumoniae serotypes in children suffering from acute otitis media or invasive pneumococcal disease and to compare a coverage of serotypes by individual pneumococcal vaccines.
Children suffering from acute otitis media and invasive pneumococcal disease were analysed in the Czech Republic from October 1999 to November 2000. Serotyping was performed by the quellung technique using antisera from Statens Serum Institute (Denmark).
The most frequent serotypes in patients with acute otitis media were 3, 19F, 23F, 14, 9V, 1, 6B, 11A and 28F. Vaccine coverage for the identified serotypes in acute otitis media patients was 52.1 per cent for the 7-valent vaccine, 57.8 per cent for the 9-valent vaccine and 75.7 per cent for the 11-valent form of the vaccine. In 108 patients with invasive pneumococcal disease, the most frequent serotypes were 6B, 9V, 14, 19F, 3 and 23F. Vaccine coverage for the identified serotypes in patients with invasive pneumococcal disease was 62 per cent for the 7-valent vaccine, 66.4 per cent for the 9-valent vaccine and 77.5 per cent for the 11-valent form of the vaccine.
INTERPRETATION & CONCLUSION: Vaccine coverage for the identified serotypes for the 11-valent pneumococcal vaccine was better than the other two vaccines.
儿童专用型肺炎球菌疫苗的可及性是一个全球性问题。在引入专用型疫苗之前,有必要研究一个国家中流行的血清型。本研究的目的是分析患有急性中耳炎或侵袭性肺炎球菌病的儿童中肺炎链球菌血清型的流行情况,并比较各肺炎球菌疫苗对血清型的覆盖范围。
1999年10月至2000年11月期间,对捷克共和国患有急性中耳炎和侵袭性肺炎球菌病的儿童进行了分析。使用丹麦国家血清研究所提供的抗血清,通过荚膜肿胀技术进行血清分型。
急性中耳炎患者中最常见的血清型为3型、19F型、23F型、14型、9V型、1型、6B型、11A型和28F型。对于急性中耳炎患者中已确定的血清型,7价疫苗的覆盖率为52.1%,9价疫苗为57.8%,11价疫苗为75.7%。在108例侵袭性肺炎球菌病患者中,最常见的血清型为6B型、9V型、14型、19F型、3型和23F型。对于侵袭性肺炎球菌病患者中已确定的血清型,7价疫苗的覆盖率为62%,9价疫苗为66.4%,11价疫苗为77.5%。
11价肺炎球菌疫苗对已确定血清型的覆盖效果优于其他两种疫苗。